Thromb Haemost 1995; 74(06): 1606-1607
DOI: 10.1055/s-0038-1649990
Letter to the Editor
Schattauer GmbH Stuttgart

Laboratory Diagnosis of APC-Resistance in Patients with Lupus Anticoagulant

Piedad Villa
Department of Clinical Pathology and Coagulopathy Unit, La Fe University Hospital, Valencia, Spain
,
Justo Aznar
Department of Clinical Pathology and Coagulopathy Unit, La Fe University Hospital, Valencia, Spain
,
Juan I Jorquera
Department of Clinical Pathology and Coagulopathy Unit, La Fe University Hospital, Valencia, Spain
,
Pilar Casaña
Department of Clinical Pathology and Coagulopathy Unit, La Fe University Hospital, Valencia, Spain
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 21. Juli 1995

Accepted after revision 25. August 1995

Publikationsdatum:
10. Juli 2018 (online)

 
  • References

  • 1 Bertina RM, Koeleman BP C, Roster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67
  • 2 Jorquera JI, Montoro JM, Fernández MA, Aznar JA, Aznar J. Modified test for activated protein C resistance. Lancet 1994; 344: 1162-1163
  • 3 Halbmayer WM, Haushofer A, Schӧn R, Fischer M. Influence of lupus anticoagulant on a commercially available kit for APC-resistancc. Thromb Haemost 1994; 72: 643-651
  • 4 Villa P, Aznar J, Jorquera JI, Mira Y, Vayá A, Fernández MA. Inherited homozygous resistance to activated protein C. Thromb Haemost 1995; 74: 794-795
  • 5 Dahlbäck B. Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism J Clin Invest 1994; 94: 923-927
  • 6 Pötzsch B, Kawamura H, Preissner KT, Schmidt M, Seelig Ch, Müller-Berg-haus G. Acquired protein C dysfunction but not decreased activity of thrombomodulin is a possible marker of thrombophilia in patients with lupus anticoagulant. J Lab Clin Med 1995; 125: 56-65